In addition, we investigated by immunohistochemistry the expression of BAFF, APRIL and TWEAK, as well as their receptors in a series of 56 gliomas, in order to identify possible new biological signatures in the complex behavior of these neoplasms. This evidence concerns the gene TNFSF13 and central nervous system cancer.